FGI-106 tetrahydrochloride

• CAT Number: I015537
• CAS Number: 1149348-10-6
• Molecular Formula: C₂₈H₄₂Cl₄N₆
• Molecular Weight: 604.49
• Purity: ≥95%
• Target: Dengue virus
• IUPAC Name: 1-N,7-N-bis[3-(dimethylamino)propyl]-3,9-dimethylquinolino[8,7-h]quinoline-1,7-diamine;tetrahydrochloride
• InChI: InChI=1S/C28H38N6.4ClH/c1-19-17-25(29-13-7-15-33(3)4)23-11-10-22-21(27(23)31-19)9-12-24-26(18-20(2)32-28(22)24)30-14-8-16-34(5)6;;;;/h9-12,17-18H,7-8,13-16H2,1-6H3,(H,29,31)(H,30,32);4*1H
• InChIKey: YUQCVPFHAFZFPV-UHFFFAOYSA-N
• SMILES: CC1=CC(=C2C=CC3=C(C2=N1)C=CC4=C(C=C(N=C34)C)NCCCN(C)C)NCCCN(C)C.Cl.Cl.Cl.Cl

FGI-106 Tetrahydrochloride（Cat No.:I015537）is an experimental antiviral compound with broad-spectrum activity against multiple viral families, including filoviruses and arenaviruses. Known for its unique mechanism, FGI-106 disrupts viral entry and replication, which makes it a promising candidate for treating high-risk viral infections such as Ebola and Marburg. The tetrahydrochloride form enhances solubility and stability, facilitating its use in research and potential therapeutic applications. With its potent efficacy in preclinical studies, FGI-106 is being investigated for use in viral outbreak scenarios, adding significant value to antiviral drug development efforts.

Reference

[1]. Aman MJ, et al. Development of a broad-spectrum antiviral with activity against Ebola virus. Antiviral Res. 2009 Sep;83(3):245-51.